FH and cancer: In the entire BRCA-positive group, there was a similar difference of 70.3 MN/1000 (s.e. 18.9; 95% CL 32.8–107.9, P<0.001) between positive BRCA patients with FH positive and controls (subjects without cancer, BRCA negatives and with negative FH for BC).